Cargando...
Barriers to buprenorphine expansion in Ohio: A time-elapsed qualitative study
Buprenorphine partial opioid agonist pharmacotherapy, a key treatment for opioid use disorders (OUDs), is underutilized in the United States. Qualitative interviews, conducted in 2012/2013 and repeated in 2015, identified systemic barriers to providing buprenorphine treatment in Ohio. A representati...
Gardado en:
| Publicado en: | J Psychoactive Drugs |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6667294/ https://ncbi.nlm.nih.gov/pubmed/30732542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/02791072.2019.1566583 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|